ARTICLE | Clinical News
Cephalon, Chiron regulatory update
July 1, 1996 7:00 AM UTC
The FDA approved a Treatment IND for CEPH's Myotrophin ( IGF-1) for ALS patients. CEPH and partner CHIR will announce a patient access program after consultations with the agency (see BioCentury Extra...